Home/Buzzard Pharmaceutical/Chris Nowak

CN

Chris Nowak

Chief Medical Officer

Buzzard Pharmaceutical

Therapeutic Areas

Buzzard Pharmaceutical Pipeline

Drug	Indication	Phase
Isunakinra	Microsatellite Stable, KRAS-mutated Colorectal Cancer	Phase 2A

Leadership Team at Buzzard Pharmaceutical

Maarten de Château

Chief Executive Officer

Director of Clinical Operations

Hans Olivecrona

Chief Scientific Officer

View full Buzzard Pharmaceutical profile